Related Experiment Videos
Platelet paroxetine binding and light therapy in winter depression
E T Mellerup1, I Errebo, J Molin
1Department of Psychiatry, Rigshospitalet, University of Copenhagen, Denmark.
Journal of Affective Disorders
|September 1, 1993
Summary
Light therapy significantly reduced serotonin transporters in patients with winter depression who responded to treatment. Non-responders had fewer transporters initially, with no significant change observed after light therapy.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Seasonal Affective Disorder (SAD), or winter depression, is a mood disorder linked to reduced sunlight exposure.
- Serotonin plays a crucial role in mood regulation, and its uptake is mediated by serotonin transporters.
- Platelets offer a accessible model for studying serotonin transporter function.
Purpose of the Study:
- To investigate the impact of light therapy on serotonin transporter levels in patients with seasonal affective disorder.
- To explore the relationship between treatment response and baseline serotonin transporter levels.
Main Methods:
- Utilized [3H]paroxetine binding assays to quantify platelet serotonin transporters.
- Measured serotonin transporter numbers before and after light therapy in SAD patients.
- Categorized patients into responders and non-responders based on treatment outcome.
Main Results:
- A significant decrease in platelet serotonin transporters was observed in patients who responded to light therapy.
- Patients who did not respond to light therapy exhibited lower baseline serotonin transporter levels.
- No significant change in serotonin transporter numbers occurred in non-responders post-treatment.
Conclusions:
- Light therapy may modulate serotonin transporter function in seasonal affective disorder.
- Baseline serotonin transporter levels might predict treatment response to light therapy.
- Reduced serotonin transporter levels may be associated with non-response to light therapy in SAD.